Copyright
©The Author(s) 2016.
World J Gastroenterol. Mar 14, 2016; 22(10): 2993-3005
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2993
Published online Mar 14, 2016. doi: 10.3748/wjg.v22.i10.2993
Table 1 Baseline characteristics of 316 patients with 404 hepatocellular carcinomas n (%)
| Characteristics | Value |
| Age (yr) | |
| Mean (range) | 60.1 ± 10.8 (24-87) |
| Patients aged ≥ 60 yr | 140 (44.3) |
| Sex | |
| Males | 250 (79.1) |
| Females | 66 (20.9) |
| Etiology of cirrhosis | |
| HBV | 231 (86.6) |
| HCV | 37 (10.2) |
| Alcohol | 4 (1.9) |
| Others | 6 (1.3) |
| Pre-RFA serum AFP | |
| < 20 ng/mL | 177 (56.0) |
| ≥ 20 ng/mL | 139 (44.0) |
| Child-Pugh class | |
| A | 250 (77.0) |
| B | 57 (20.1) |
| C | 9 (2.8) |
| Serum ALT/AST | |
| Normal | 229 (72.5) |
| Elevated | 87 (27.5) |
| Tumor no | |
| Single | 248 (78.4) |
| ≥ 2 | 68 (21.6) |
| Tumor size (cm) | |
| Mean (range) | 3.2 ± 1.1(1.0-5.0) |
| Tumor > 3 cm | 169 (53.4) |
- Citation: Yang W, Yan K, Goldberg SN, Ahmed M, Lee JC, Wu W, Zhang ZY, Wang S, Chen MH. Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment. World J Gastroenterol 2016; 22(10): 2993-3005
- URL: https://www.wjgnet.com/1007-9327/full/v22/i10/2993.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i10.2993